Generic Drugmakers Conspired to Inflate Prices Up to 1,000%, State Prosecutors Say
Over golf outings and at dinners, more than a dozen competitors agreed to keep prices for H.I.V., asthma and cancer drugs artificially high, 44 states allege in a new lawsuit.
Source: NYT Health - Category: Consumer Health News Authors: HEATHER MURPHY Tags: Drugs (Pharmaceuticals) Generic Brands and Products Antitrust Laws and Competition Issues Prices (Fares, Fees and Rates) Health Insurance and Managed Care New Jersey Mylan Inc Pfizer Inc Teva Pharmaceutical Industries Ltd Novartis AG Source Type: news
More News: Asthma | Cancer | Cancer & Oncology | Health | Health Insurance | Insurance | Lawsuits | Legislation | Managed Care | Pfizer